Value assessment should include all aspects of value that matter to patients
We need to move toward a more value-driven health care system that centers around patients’ needs. Sound evidence can help guide us toward that, and […]
We need to move toward a more value-driven health care system that centers around patients’ needs. Sound evidence can help guide us toward that, and […]
How does ICER plan to determine whether health plans offer fair access to pharmaceuticals? I summarized their approach last year as outlined in their white […]
A new report from Partnership for Health Analytic Research or PHAR describes how value assessments that use traditional cost-effectiveness analyses can overlook important health disparities […]
Last week at the ISPOR annual international meeting, PhRMA partnered with multiple organizations committed to advancing value assessment research and methods. We worked with a […]
On June 10, I will be presenting at ISPOR’s Summit on “Value Assessment: New Insights, Approaches, and Applications,” which will highlight evolving practices, new methods, […]
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The […]
A new drug comes on the market. Is the health benefit worth the cost? What is it’s value? Value assessment frameworks are one way to […]
Cost effectiveness analysis aims to capture identify (and monetize) all of a treatments benefits, risk and costs and then determine if the treatment is worth […]
COVID-19 is a global pandemic and finding a vaccine for COVID-19 would be a boon to societal. The value would be enormous. One study found […]
Copyright © 2024 | WordPress Theme by MH Themes